<i>IDH</i> Mutations in Glioma: Double-Edged Sword in Clinical Applications? by Alisan Kayabolen, Ebru Yilmaz, Tugba Bagci-Onder

Get full text

Editorial: Cell Death and Targeted Cancer Therapies by Tugba Bagci-Onder, Ozgur Kutuk, Triona Ni Chonghaile, Uwe Knippschild

Get full text

Evaluating the effect of therapeutic stem cells on TRAIL resistant and sensitive medulloblastomas. by Irina Nesterenko, Simone Wanningen, Tugba Bagci-Onder, Maarten Anderegg, Khalid Shah

Get full text

Glioma-on-a-Chip Models by Merve Ustun, Sajjad Rahmani Dabbagh, Irem Sultan Ilci, Tugba Bagci-Onder, Savas Tasoglu

Get full text

Drug Repositioning Screen on a New Primary Cell Line Identifies Potent Therapeutics for Glioblastoma by Filiz Senbabaoglu, Filiz Senbabaoglu, Ali Cenk Aksu, Ali Cenk Aksu, Ahmet Cingoz, Ahmet Cingoz, Fidan Seker-Polat, Fidan Seker-Polat, Esra Borklu-Yucel, İhsan Solaroglu, İhsan Solaroglu, İhsan Solaroglu, Tugba Bagci-Onder, Tugba Bagci-Onder

Get full text

Exploiting epigenetic targets to overcome taxane resistance in prostate cancer by Buse Cevatemre, Ipek Bulut, Beyza Dedeoglu, Arda Isiklar, Hamzah Syed, Ozlem Yedier Bayram, Tugba Bagci-Onder, Ceyda Acilan

Get full text

New trends in cell death: overview of the International Society of Cell Death (ICDS) annual meeting in Johannesburg South Africa (May 19-22, 2023) by Marianne J. Cronjé, Varsha Gadiyar, Jerry Edward Chipuk, Tugba Bagci-Onder, Dmitri Krysko, Raymond B. Birge, Richard A. Lockshin, Zahra Zakeri

Get full text

Experimental data on novel Fe(III)-complexes containing phenanthroline derivatives for their anticancer properties by Cristina P. Matos, Zelal Adiguzel, Yasemin Yildizhan, Buse Cevatemre, Tugba Bagci-Onder, Ozge Cevik, Patrique Nunes, Liliana P. Ferreira, Maria Deus Carvalho, Débora L. Campos, Fernando R. Pavan, João Costa Pessoa, Maria Helena Garcia, Ana Isabel Tomaz, Isabel Correia, Ceyda Acilan

Get full text

EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities by Ozlem Yedier-Bayram, Bengul Gokbayrak, Alisan Kayabolen, Ali Cenk Aksu, Ayse Derya Cavga, Ahmet Cingöz, Ezgi Yagmur Kala, Goktug Karabiyik, Rauf Günsay, Beril Esin, Tunc Morova, Fırat Uyulur, Hamzah Syed, Martin Philpott, Adam P. Cribbs, Sonia H. Y. Kung, Nathan A. Lack, Tamer T. Onder, Tugba Bagci-Onder

Get full text

Identification of selective SWI/SNF dependencies in enzalutamide-resistant prostate cancer by Bengul Gokbayrak, Umut Berkay Altintas, Shreyas Lingadahalli, Tunc Morova, Chia-Chi Flora Huang, Betul Ersoy Fazlioglu, Ivan Pak Lok Yu, Batuhan M. Kalkan, Paloma Cejas, Sonia H. Y. Kung, Ladan Fazli, Akane Kawamura, Henry W. Long, Ceyda Acilan, Tamer T. Onder, Tugba Bagci-Onder, James T. Lynch, Nathan A. Lack

Get full text

Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival by Ezgi Ozyerli-Goknar, Ezgi Yagmur Kala, Ali Cenk Aksu, Ipek Bulut, Ahmet Cingöz, Sheikh Nizamuddin, Martin Biniossek, Fidan Seker-Polat, Tunc Morova, Can Aztekin, Sonia H. Y. Kung, Hamzah Syed, Nurcan Tuncbag, Mehmet Gönen, Martin Philpott, Adam P. Cribbs, Ceyda Acilan, Nathan A. Lack, Tamer T. Onder, H. T. Marc Timmers, Tugba Bagci-Onder

Get full text